Under the theme "A Blueprint for Action in Asia," the AVPN Global Conference 2026 took place from August 25–27, 2026, at Bharat Mandapam, New Delhi, India. Participation in the AVPN Global Conference forum opens opportunities to expand international networks, build strategic partnerships, and identify new funding sources for various innovation and sustainable development programs.

Prof. Tatacipta took part in the session "The Next Frontier in Global Health: Convergence, Prevention, and Innovation." This session addressed one of the key challenges in the future of health development: how to deliver health innovations that are not only scientifically excellent but also capable of providing real, affordable, and sustainable benefits for society.

Prof. Tatacipta discussed alongside several figures from various sectors, namely Chetna Gala Sinha, Founder and Chairperson of Mann Deshi Bank & Mann Deshi Foundation, India; Jesper Moller, Deputy Representative for Programmes, UNICEF India; and Usha Viswanathen, Head of Health and Well-being, Temasek Foundation. The discussion was moderated by Prof. Sankalp Chaturvedi, Co-Director of the Gandhi Centre for Inclusive Innovation and Associate Dean for People and Culture, Imperial College Business School.

^Vent-I.

During the discussion, Prof. Tatacipta stated that Indonesia's challenge in health development lies not merely in a shortage of ideas or innovation, but in the ability to bring proven solutions to a wider and more sustainable scale of implementation. A number of innovations developed by ITB serve as examples of how research and technology development can deliver real contributions to society. These include the Red and White Vaccine (Vaksin Merah Putih), developed through a consortium of six institutions during the pandemic; Vent-I, a ventilator that has been used at around a thousand hospital service points; as well as NIVA and heartGO, developed to support cardiovascular risk detection without requiring people to visit a hospital in person.

^{prosthetic leg.}

Prof. Tatacipta also highlighted a particularly tangible example of social impact from ITB's innovations: a low-cost prosthetic leg designed to allow users to perform prayers (salat) while seated in a cross-legged position, offering an alternative solution for accident victims who have undergone amputation. He noted that although the product was developed with a commercial orientation in order to keep production costs low, its social impact on users has been substantial.

On the other hand, Indonesia still faces various challenges in health and in meeting the basic needs of society, such as basic nutritional needs and the prevalence of stunting. According to him, the strength of universities lies in their ability to bring these various disciplines together. Digital technology, artificial intelligence, data analytics, biosciences, pharmacy, engineering, as well as social sciences, economics, and business can be combined to produce more comprehensive health solutions.

Prof. Tatacipta also emphasized an important challenge for universities. "The measure of successful innovation is not just publications or technological sophistication, but how far that knowledge can be translated into solutions and deliver real impact for society," he affirmed.

This requires an ecosystem connecting universities, government, industry, investors, philanthropic institutions, healthcare workers, and the public. Such collaboration is needed from technology development through to financing, implementation, and scaling up innovation.

ITB's participation in the AVPN Global Conference 2026 further affirms the strategic role of universities as a bridge between knowledge, innovation, and impact. Through the convergence of sciences and global collaboration, ITB has the opportunity to strengthen its contribution to building health innovations that are not only world-class, but also relevant and deliver real benefits for Indonesia and Asia.